Key statistics
On Thursday, Hansa Biopharma AB (HNSA:STO) closed at 40.98, -4.65% below its 52-week high of 42.98, set on Oct 01, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 39.40 |
|---|---|
| High | 41.90 |
| Low | 38.38 |
| Bid | 40.98 |
| Offer | 40.98 |
| Previous close | 38.74 |
| Average volume | 442.64k |
|---|---|
| Shares outstanding | 101.76m |
| Free float | 48.58m |
| P/E (TTM) | -- |
| Market cap | 3.94bn SEK |
| EPS (TTM) | -6.44 SEK |
Data delayed at least 15 minutes, as of Feb 12 2026 17:00 GMT.
More ▼
- Hansa Biopharma Reports Fourth Quarter and Full-Year 2025 Financial Results
- Hansa Biopharma Reports Fourth Quarter and Full-Year 2025 Financial Results
- Hansa Biopharma has won the 2025 SwedenBIO Award
- Hansa Biopharma has won the 2025 SwedenBIO Award
- Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation
- Hansa Biopharma Submits BLA to FDA for Imlifidase in desensitization for Kidney Transplantation
More ▼
